Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03) - Concepedia

Concepedia

Publication | Open Access

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

DOI Full Paper Access

217

Citations

25

References

2021

Year

Amar Gajjar, Giles Robinson, Kyle Smith, Tong Lin, Thomas E. Merchant, Murali Chintagumpala, Anita Mahajan, Jack Su, Éric Bouffet, Ute Bartels,

Journal of Clinical Oncology

Abstract

These results establish a new risk stratification for future medulloblastoma trials.

References

	Year	Citations

Page 1